A Phase 3, Open-label, Randomized Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) versus Epoetin Alfa for the Treatment of Anemia due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in ESA Naive Subjects who require Red Blood Cell Transfusions.

Project: Research

Project Details

StatusActive
Effective start/end date15/07/19 → 3/12/26

Keywords

  • Malignant Haematology
  • Anaemia
  • Blood transfusions
  • Clinical trial

Clinical Trial Phase

  • Phase III (a & b)